1. DOP10 Serum N-glycomic biomarkers predict treatment escalation in inflammatory bowel disease. (25th January 2019) Authors: Shubhakar, A; Jansen, B; Adams, A; Reiding, K; Ventham, N; Bergemalm, D; Urbanowicz, P; Gardner, R; Halfvarson, J; Satsangi, J; Fernandes, D; Wuhrer, M; Spencer, D Journal: Journal of Crohn's and colitis Issue: Volume 13(2019)Supplement 1 Page Start: S032 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗